HeartWare International, Inc. Announces Concurrent Public Offerings of Convertible Senior Notes and Common Stock
FRAMINGHAM, Mass. and SYDNEY, Dec. 9, 2010 /PRNewswire-FirstCall/ -- HeartWare International, Inc. (Nasdaq: HTWR, ASX: HIN) ("HeartWare") announced today its intention to offer, subject to market and other conditions, $100 million principal amount of convertible senior notes due 2017 (the "notes") pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission ("SEC") today. HeartWare also intends to grant the underwriters an option to purchase up to an additional $15 million principal amount of notes to cover over-allotments, if any.
Concurrently with the notes offering, Apple Tree Partners I, L.P., one of HeartWare's existing stockholders, intends to offer, subject to market and other conditions, 1,000,000 shares of HeartWare's common stock pursuant to an effective shelf registration statement filed with the SEC today. Apple Tree Partners I, L.P. will also grant the underwriters an option to purchase up to 150,000 additional shares to cover over-allotments, if any. The completion of the common stock offering is not contingent upon the completion of the notes offering and the notes offering is not contingent upon the completion of the common stock offering.
HeartWare intends to use the net proceeds from the notes offering for general corporate and working capital purposes, including, but not limited to, expansion of its manufacturing capabilities and/or licensing of or investment in complementary products, technologies or businesses. HeartWare will not receive any of the proceeds from the common stock offering.
J.P. Morgan Securities LLC is acting as the sole book-running manager for both the convertible notes and common stock offerings.
This press release shall not constitute an offer to sell or a solicitation of an offer to buy any securities nor shall there be any sale of these securities in any state in which such offer, solicitation or sa